Huapont Life Science Co (SZSE:002004) Other Financing: ¥35 Mil (TTM As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SZSE:002004 Huapont Life Science Co Ltd SZSE:002004
65 GF Score
Price ¥4.38
GF Value ¥4.43
Valuation Fairly Valued
! 6 Warning Signs
View Full Analysis

What is Huapont Life Science Co Other Financing?

Huapont Life Science Co SZSE:002004 -0.23% 65 Other Financing is ¥35 Mil as of Jun. 2026. GuruFocus rates SZSE:002004 with a GF Score™ of 65/100 and a GF Value™ of ¥4.43 (Fairly Valued). The stock has 6 warning signs investors should review.

Huapont Life Science Co's Other Financing for the three months ended in Jun. 2026 was ¥-305 Mil.

Huapont Life Science Co's Other Financing for the trailing twelve months (TTM) ended in Jun. 2026 was ¥35 Mil.

Huapont Life Science Co Other Financing Historical Data

* Premium members only.

The historical data trend for Huapont Life Science Co's Other Financing can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Huapont Life Science Co Other Financing Chart

Huapont Life Science Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Other Financing
Get a 7-Day Free Trial Premium Member Only Premium Member Only -535.17 -150.99 -34.82 -691.79 -111.86

Huapont Life Science Co Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Other Financing Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -301.64 -1.52 525.51 -184.78 -304.57
SZSE:002004
65GF Score
Huapont Life Science Co Ltd SZSE:002004
Other Financing is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Huapont Life Science Co Other Financing Calculation

Other Financing represents other cash flow from financing activity that not otherwise classified, which includes:
Proceeds From Stock Option Exercised
Other Financing Charges

Other Financing for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥35 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Other Financing →
What does a Other Financing of ¥35 Mil mean?
Huapont Life Science Co (SZSE:002004) has a Other Financing of ¥35 Mil as of Jun. 2026. Other Financing represents other cash flow from financing activity that not otherwise classified. View historical data for Huapont Life Science Co and its competitors.
Is Huapont Life Science Co's Other Financing too high?
Huapont Life Science Co's current Other Financing is ¥35 Mil. Overall, Huapont Life Science Co has a GF Score™ of 65/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Huapont Life Science Co's Other Financing compare to CTVA and CF?
Huapont Life Science Co's Other Financing of ¥35 Mil can be compared against companies in the Agriculture industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Financing for an Agriculture company?
A good Other Financing depends on the Agriculture industry context. However, Other Financing should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Financing mean?
A high Other Financing can signal that a stock is expensive relative to its fundamentals. Other Financing represents other cash flow from financing activity that not otherwise classified. View historical data for Huapont Life Science Co and its competitors. Huapont Life Science Co's current Other Financing is ¥35 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Huapont Life Science Co stock overvalued right now?
Based on GuruFocus' analysis, Huapont Life Science Co (SZSE:002004) is currently considered Fairly Valued. The stock's GF Value™ is ¥4.43, compared to a current price of ¥4.38 — trading 1.1% below its estimated fair value. The current Other Financing is ¥35 Mil. Huapont Life Science Co's overall GF Score™ is 65/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Financing calculated?
Other Financing is calculated from a company's financial statements. For Huapont Life Science Co (SZSE:002004), the current Other Financing is ¥35 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Huapont Life Science Co (SZSE:002004) Overvalued in 2026?

Based on GuruFocus' analysis, Huapont Life Science Co stock appears to be undervalued. The current stock price of ¥4.38 is trading 1.1% below its estimated GF Value™ of ¥4.43. GuruFocus considers Huapont Life Science Co to be Fairly Valued.

Key valuation signals for SZSE:002004:

  • Other Financing: ¥35 Mil
  • GF Value™: ¥4.43 vs. price of ¥4.38 (1.1% below fair value)
  • GF Score™: 65/100 with 6 warning signs

No single metric tells the full story. See the SZSE:002004 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Huapont Life Science Co Business Description

Address No. 69, Renhe Xingguang Avenue, Yubei District, Chongqing, CHN, 401121
Huapont Life Science Co Ltd is a China-based company engaged in the manufacturing and distribution of pharmaceutical products. In addition, the company is also engaged in the agrochemical business and medical business. The agrochemical department is mainly engaged in the research and development, production, sales, and technical services of pesticide intermediates, original drugs, and preparations.
65GF Score

Get the complete analysis for SZSE:002004

Other Financing is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥4.38
Price
¥4.43
GF Value